Answers are grounded in this paper and cite their sources.
Gene therapy is a rapidly expanding area of research, with a growing number of publications and clinical trials since the advent of the field. Despite substantial advances, one of the most significant roadblocks faced during gene therapy is the failure to efficiently deliver genetic material into target cells at levels sufficient to achieve a therapeutic effect. Therefore, an active and crucial area of research is the development of gene therapy platforms that can efficiently and safely transfect cells with low levels of cytotoxicity and immunogenicity. Toward this, cationic polymers offer a desirable platform due to their ability to self-complex with genetic material, ability to transfect cells, their ease and controllability of production, and their low immunogenicity. Though cationic polymers can induce some level of toxicity due to their positive charge and, display lower transfection efficacy compared to virus-based gene transfection agents, alterations can be made to the polymers (i.e., charge, molecular architecture, molecular weight, etc.) to help increase their transfection efficiency and mitigate drawbacks. In this study, we explored such alterations with a cationic polymer, branched poly-l-lysine (BPL), with lysine as the repeating unit, for their ability to transfect cells using plasmid DNA (pDNA) as genetic material.
No takes yet. Share an insight, caveat, or question.
Angel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: